Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 5 Post-COVID-19 syndrome severity in rheumatic disease patients according to vaccination doses received

From: Assessment of symptoms of the post-COVID-19 syndrome in patients with different rheumatic diseases

Parameter

mean ± SD

Single vaccine dose

Two vaccine doses

P value

FSS score

42.56 ± 10.91

32.48 ± 11.192

0.005

SF-MPQ-2

26.25 ± 9.09

19.64 ± 10.037

0.091

HADS (anxiety)

14.56 ± 2.828

11.28 ± 2.836

0.001

HADS(depression)

14.31 ± 3.049

11.44 ± 3.31

0.009

MMSE score

19.75 ± 3.1

22.4 ± 2.843

0.012

  1. The used test was Kruskal–Wallis test. FSS fatigue severity scale, HADS hospital anxiety and depression scale, SF-MPQ-2 short-form McGill pain questionnaire, MMSE mini–mental state examination. Bold values are significant at P ≤ 0.05
Back to article page